Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2025-09-17 00:00:00 ET · period of report 2025-09-16 · accession 0001193125-25-206494 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-09-17 | 2025-09-16 | AXSM | Jacobson Mark L. | COO | S - Sale+OE | $114.48 | -45.8K | 0 | -100% | -$5.24M |
| DMT | 2025-09-17 | 2025-09-16 | AXSM | Jacobson Mark L. | COO | M - OptEx | $4.91 | +40.0K | 40.0K | New | +$196.5K |
| DMT | 2025-09-17 | 2025-09-16 | AXSM | Jacobson Mark L. | COO | M - OptEx | $0.00 | -40.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-16 | S | D | 5,783 | $116.19 | 0 | D | — | — | (F5) Represents the sale price of all shares in an open market transaction. |
| 2 | Common | Common Stock | 2025-09-16 | M | A | 25,000 | $4.95 | 25,000 | D | — | — | |
| 3 | Common | Common Stock | 2025-09-16 | M | A | 15,000 | $4.85 | 40,000 | D | — | — | |
| 4 | Common | Common Stock | 2025-09-16 | S | D | 40,000 | $114.23 | 0 | D | — | — | (F6) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $112.93 and $116.87. |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-09-16 | M | D | 25,000 | $0.00 | 0 | D | $4.95 · 2018-03-15 to 2027-03-15 | 25,000 Common Stock | |
| 6 | Derivative | Stock Option (Right to Buy) | 2025-09-16 | M | D | 15,000 | $0.00 | 0 | D | $4.85 · 2018-09-13 to 2027-09-13 | 15,000 Common Stock |